306 related articles for article (PubMed ID: 37922034)
1. New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism.
Kleuser B; Schumacher F; Gulbins E
Handb Exp Pharmacol; 2024; 284():289-312. PubMed ID: 37922034
[TBL] [Abstract][Full Text] [Related]
2. Bioactive Sphingolipids in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
Koike K; Berdyshev EV; Bowler RP; Scruggs AK; Cao D; Schweitzer KS; Serban KA; Petrache I
Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S249-S252. PubMed ID: 30759004
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipids in lung growth and repair.
Tibboel J; Reiss I; de Jongste JC; Post M
Chest; 2014 Jan; 145(1):120-128. PubMed ID: 24394822
[TBL] [Abstract][Full Text] [Related]
4. Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
Petrache I; Berdyshev EV
Annu Rev Physiol; 2016; 78():463-80. PubMed ID: 26667073
[TBL] [Abstract][Full Text] [Related]
5. CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis.
Westhölter D; Schumacher F; Wülfinghoff N; Sutharsan S; Strassburg S; Kleuser B; Horn PA; Reuter S; Gulbins E; Taube C; Welsner M
J Cyst Fibros; 2022 Jul; 21(4):713-720. PubMed ID: 35168870
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipids in the lungs.
Uhlig S; Gulbins E
Am J Respir Crit Care Med; 2008 Dec; 178(11):1100-14. PubMed ID: 18755926
[TBL] [Abstract][Full Text] [Related]
7. Iron and Sphingolipids as Common Players of (Mal)Adaptation to Hypoxia in Pulmonary Diseases.
Ottolenghi S; Zulueta A; Caretti A
Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906427
[TBL] [Abstract][Full Text] [Related]
8. The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.
Thomas JM; Sudhadevi T; Basa P; Ha AW; Natarajan V; Harijith A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163176
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipid metabolites in inflammatory disease.
Maceyka M; Spiegel S
Nature; 2014 Jun; 510(7503):58-67. PubMed ID: 24899305
[TBL] [Abstract][Full Text] [Related]
10. Role of Sphingolipids in the Pathobiology of Lung Inflammation.
Ghidoni R; Caretti A; Signorelli P
Mediators Inflamm; 2015; 2015():487508. PubMed ID: 26770018
[TBL] [Abstract][Full Text] [Related]
11. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
12. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
Gardner AI; Haq IJ; Simpson AJ; Becker KA; Gallagher J; Saint-Criq V; Verdon B; Mavin E; Trigg A; Gray MA; Koulman A; McDonnell MJ; Fisher AJ; Kramer EL; Clancy JP; Ward C; Schuchman EH; Gulbins E; Brodlie M
Am J Respir Crit Care Med; 2020 Oct; 202(8):1133-1145. PubMed ID: 32569477
[No Abstract] [Full Text] [Related]
14. Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases.
Drexler Y; Molina J; Mitrofanova A; Fornoni A; Merscher S
J Am Soc Nephrol; 2021 Jan; 32(1):9-31. PubMed ID: 33376112
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-Phosphate as Essential Signaling Molecule in Inflammatory Skin Diseases.
Kleuser B; Bäumer W
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674974
[TBL] [Abstract][Full Text] [Related]
16. Ceramide signaling in the gut.
Li Y; Nicholson RJ; Summers SA
Mol Cell Endocrinol; 2022 Mar; 544():111554. PubMed ID: 34998898
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipid Metabolism and Signaling in Endothelial Cell Functions.
Sasset L; Di Lorenzo A
Adv Exp Med Biol; 2022; 1372():87-117. PubMed ID: 35503177
[TBL] [Abstract][Full Text] [Related]
18. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
19. The involvement of sphingolipids in chronic obstructive pulmonary diseases.
Petrache I; Petrusca DN
Handb Exp Pharmacol; 2013; (216):247-64. PubMed ID: 23563660
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage.
Khan SA; Goliwas KF; Deshane JS
Front Physiol; 2021; 12():760638. PubMed ID: 34690821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
